Leighanne Oh

Leighanne Oh

Vice President atAscenta CapitalNew York

Leighanne Oh is a Vice President at Ascenta Capital, focusing on investment opportunities. She has experience in biotech and life sciences investing, with prior roles at Novo Holdings, Sofinnova Investments, and Jefferies.

What Leighanne can write

Writes checks of$10M to $30M
Comes in atNot reportedLead preference not reported
Email the firm[email protected]The firm's own inbox for founders.

Ascenta Capital writes $10M to $30M checks, larger than 97% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Ascenta Capital.

Career

  1. Jefferies · Analyst on the Healthcare Investment Banking team
  2. SoBE Bioequities
  3. Sofinnova Investments · private investor
    2019-2022
  4. Novo Holdings
    2022-2024
  5. Ascenta Capital · Vice President
    Now
  6. SoBE Bioequities · investor
  7. Sofinnova · private investor
    2019-2022

Focus

biotechlife sciencespublic investmentsprivate investmentsclinical stageclinical stage investments

Education

Duke University

Also at Ascenta Capital

Alert me when Ascenta Capital is active

One email when Leighanne's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Leighanne Oh?

Leighanne Oh is a Vice President at Ascenta Capital, focusing on investment opportunities. She has experience in biotech and life sciences investing, with prior roles at Novo Holdings, Sofinnova Investments, and Jefferies.

How much does Leighanne Oh invest?

Leighanne Oh invests through Ascenta Capital, which writes checks of $10M to $30M.

How do I pitch Leighanne Oh?

Email [email protected], the firm's inbox for founders, and name Leighanne in the subject. A warm intro from a founder Ascenta Capital backed works better.

What did Leighanne Oh do before Ascenta Capital?

Analyst on the Healthcare Investment Banking team at Jefferies; SoBE Bioequities; private investor at Sofinnova Investments; Novo Holdings; investor at SoBE Bioequities; private investor at Sofinnova.

Last updated 2026-10-15. Is this you? Ask for a correction.